<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459855</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1520</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101520</ELocationID><Abstract><AbstractText>Patients with hematological malignancies (HMs) are at high risk of respiratory viral infections due to the intrinsic deterioration of the immune system and chemotherapy treatments. In the recent past, SARS-CoV-2 respiratory viral infection has been responsible for most infectious complications in HMs. We analyzed 2950 samples from 505 patients admitted to the Hematology department from 2019 to 2023. The aim of this study was to determine the epidemiological trend of respiratory viruses in the SARS-CoV-2 era, the characteristics of the patients involved and their outcomes. In our analysis, we found a reduction in non-SARS-CoV-2 respiratory viral (NSRV) positivity during the pandemic period, although these data did not show statistical significance. Most of the HMs involved were Multiple Myeloma and Acute Myeloid Leukemia. Overall mortality rate was very low and characterized by the progression of the HMs as well as the worsening of respiratory failure. In conclusion, a reduction in non-COVID viral infections was highlighted, probably also thanks to the increase in prevention measures and environmental modifications of the viral background.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hematology Department, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli, 8 I-00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quattrone</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viscovo</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiori</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangelo</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanguinetti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9780-7059</Identifier><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagano</LastName><ForeName>Livio</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8287-928X</Identifier><AffiliationInfo><Affiliation>Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Università Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019337" MajorTopicYN="Y">Hematologic Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459855</ArticleId><ArticleId IdType="pmc">PMC11512396</ArticleId><ArticleId IdType="doi">10.3390/v16101520</ArticleId><ArticleId IdType="pii">v16101520</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holmes E.C., Goldstein S.A., Rasmussen A.L., Robertson D.L., Crits-Christoph A., Wertheim J.O., Anthony S.J., Barclay W.S., Boni M.F., Doherty P.C., et al. The origins of SARS-CoV-2: A critical review. Cell. 2021;184:4848–4856. doi: 10.1016/j.cell.2021.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC8373617</ArticleId><ArticleId IdType="pubmed">34480864</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11 March 2020.  [(accessed on 2 September 2024)]; Available online:  https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.</Citation></Reference><Reference><Citation>García L.F. Immune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol. 2020;11:1441. doi: 10.3389/fimmu.2020.01441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01441</ArticleId><ArticleId IdType="pmc">PMC7308593</ArticleId><ArticleId IdType="pubmed">32612615</ArticleId></ArticleIdList></Reference><Reference><Citation>Monticelli M., Mele B.H., Andreotti G., Cubellis M.V., Riccio G. Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19. Eur. J. Med. Genet. 2021;64:104227. doi: 10.1016/j.ejmg.2021.104227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2021.104227</ArticleId><ArticleId IdType="pmc">PMC8051015</ArticleId><ArticleId IdType="pubmed">33872774</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Guan W., Chen R., Wang W., Li J., Xu K., Li C., Ai Q., Lu W., Liang H., et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335–337. doi: 10.1016/S1470-2045(20)30096-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30096-6</ArticleId><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana L., Strasfeld L. Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient. Infect. Dis. Clin. N. Am. 2019;33:523–544. doi: 10.1016/j.idc.2019.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2019.02.004</ArticleId><ArticleId IdType="pmc">PMC7126949</ArticleId><ArticleId IdType="pubmed">30940462</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagano L., Salmanton-García J., Marchesi F., Busca A., Corradini P., Hoenigl M., Klimko N., Koehler P., Pagliuca A., Passamonti F., et al. COVID-19 infection in adult patients with hematological malignancies: A European Hematology Association Survey (EPICOVIDEHA) J. Hematol. Oncol. 2021;14:168. doi: 10.1186/s13045-021-01177-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01177-0</ArticleId><ArticleId IdType="pmc">PMC8515781</ArticleId><ArticleId IdType="pubmed">34649563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagano L., Salmanton-García J., Marchesi F., Blennow O., Gomes da Silva M., Glenthøj A., van Doesum J., Bilgin Y.M., López-García A., Itri F., et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: Results from the EPICOVIDEHA survey. Blood. 2022;140:2773–2787. doi: 10.1182/blood.2022017257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2022017257</ArticleId><ArticleId IdType="pmc">PMC9492383</ArticleId><ArticleId IdType="pubmed">36126318</ArticleId></ArticleIdList></Reference><Reference><Citation>Musto P., Salmanton-García J., Sgherza N., Bergantim R., Farina F., Glenthøj A., Seval G.C., Weinbergerová B., Bonuomo V., Bilgin Y.M., et al. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry. Hematol. Oncol. 2023;42:3240. doi: 10.1002/hon.3240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hon.3240</ArticleId><ArticleId IdType="pubmed">38050405</ArticleId></ArticleIdList></Reference><Reference><Citation>Khawaja F., Chemaly R.F. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies. Haematologica. 2019;104:1322–1331. doi: 10.3324/haematol.2018.215152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2018.215152</ArticleId><ArticleId IdType="pmc">PMC6601091</ArticleId><ArticleId IdType="pubmed">31221784</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamonti F., Cattaneo C., Arcaini L., Bruna R., Cavo M., Merli F., Angelucci E., Krampera M., Cairoli R., Della Porta M.G., et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: A retrospective, multicentre, cohort study. Lancet Haematol. 2020;7:e737–e745. doi: 10.1016/S2352-3026(20)30251-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30251-9</ArticleId><ArticleId IdType="pmc">PMC7426107</ArticleId><ArticleId IdType="pubmed">32798473</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu C.M., Ursache A.L., Feketea G., Bocsan C., Jimbu L., Mesaros O., Edwards M., Wang H., Berceanu I., Neaga A., et al. Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients? Microorganisms. 2019;7:521. doi: 10.3390/microorganisms7110521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7110521</ArticleId><ArticleId IdType="pmc">PMC6920795</ArticleId><ArticleId IdType="pubmed">31684063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabutti G., De Motoli F., Sandri F., Toffoletto M.V., Stefanati A. Viral Respiratory Infections in Hematological Patients. Infect. Dis. Ther. 2020;9:495–510. doi: 10.1007/s40121-020-00313-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-020-00313-6</ArticleId><ArticleId IdType="pmc">PMC7339094</ArticleId><ArticleId IdType="pubmed">32638228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijano D.R., Maron G., Hayden R.T. Respiratory Viral Infections in Patients with Cancer or Undergoing Hematopoietic Cell Transplant. Front. Microbiol. 2018;9:3097. doi: 10.3389/fmicb.2018.03097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.03097</ArticleId><ArticleId IdType="pmc">PMC6299032</ArticleId><ArticleId IdType="pubmed">30619176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Wang Y., Peppelenbosch M.P., Ma Z., Pan Q. Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients. Int. J. Infect. Dis. 2021;102:375–380. doi: 10.1016/j.ijid.2020.11.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.127</ArticleId><ArticleId IdType="pmc">PMC7658594</ArticleId><ArticleId IdType="pubmed">33189938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Tao X. Comparison of COVID-19 and influenza characteristics. J. Zhejiang Univ. B. 2021;22:87–98. doi: 10.1631/jzus.B2000479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000479</ArticleId><ArticleId IdType="pmc">PMC7885750</ArticleId><ArticleId IdType="pubmed">33615750</ArticleId></ArticleIdList></Reference><Reference><Citation>Micozzi A., Gentile G., Minotti C., Cartoni C., Capria S., Ballarò D., Santilli S., Pacetti E., Grammatico S., Bucaneve G., et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: Factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect. Dis. 2017;17:203. doi: 10.1186/s12879-017-2297-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2297-9</ArticleId><ArticleId IdType="pmc">PMC5345173</ArticleId><ArticleId IdType="pubmed">28283020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanternier F., Seidel D., Pagano L., Styczynski J., Mikulska M., Pulcini C., Maertens J., Munoz P., Garcia-Vidal C., Rijnders B., et al. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey. Mycoses. 2020;63:420–429. doi: 10.1111/myc.13056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13056</ArticleId><ArticleId IdType="pubmed">32009262</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N., Zhang L., Feng S. Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies. J. Fungi. 2023;9:592. doi: 10.3390/jof9050592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof9050592</ArticleId><ArticleId IdType="pmc">PMC10219352</ArticleId><ArticleId IdType="pubmed">37233303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungman P., de la Camara R., Perez-Bercoff L., Abecasis M., Campuzano J.B.N., Cannata-Ortiz M.J., Cordonnier C., Einsele H., Gonzalez-Vicent M., Espigado I., et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96:1231–1235. doi: 10.3324/haematol.2011.041913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2011.041913</ArticleId><ArticleId IdType="pmc">PMC3148919</ArticleId><ArticleId IdType="pubmed">21546495</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond M., Martin M., Lamouche-Wilquin P., Blonz G., Decamps P., Agbakou M., Desmedt L., Reignier J., Lascarrou J.-B., Canet E. Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients. Medicine. 2022;101:e32245. doi: 10.1097/MD.0000000000032245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000032245</ArticleId><ArticleId IdType="pmc">PMC9750560</ArticleId><ArticleId IdType="pubmed">36626482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo J., Kim S.C., Lee J. Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy. BMC Pulm. Med. 2024;24:259. doi: 10.1186/s12890-024-03071-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-024-03071-0</ArticleId><ArticleId IdType="pmc">PMC11129456</ArticleId><ArticleId IdType="pubmed">38797852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>